Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 40:1668-1674
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kampmann, C.
Right arrow Articles by Beck, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kampmann, C.
Right arrow Articles by Beck, M.

Cardiac manifestations of Anderson–Fabry disease in heterozygous females

Christoph Kampmann, MD*,*, Frank Baehner, MD*, Catharina Whybra*, Claudia Martin, MD*, Christiane M. Wiethoff*, Markus Ries, MD*, Andreas Gal, MD, PhD{dagger} and Michael Beck, MD, PhD*

* Division of Cardiology and Division of Lysosomal Storage Diseases, University Children’s Hospital, Mainz, Germany
{dagger} Institute of Human Genetics, University of Hamburg, Hamburg, Germany



View larger version (16K):

[in a new window]
 
Figure 1 Left ventricular mass (LVM) corrected for height plotted against age in 55 patients. There are two benchmark lines included: one at 47 g/m2.7, indicating the normal limits of LVM. Above 38.2 years of age, 25 of 28 (89.3%) patients had an increased LVM, as did 25 of 25 (100%) patients above 45 years of age. Below 38 years of age, 12 of 27 (44.4%) patients had a normal LVM.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement